Cancer symptom response as an oncology clinical trial end point-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Cancer symptom response as an oncology clinical trial end point

Published:2018-05-04 Issue:2-3 Volume:3 Page:35-46
ISSN:2380-9000
Container-title:Expert Review of Quality of Life in Cancer Care
language:en
Short-container-title:Expert Review of Quality of Life in Cancer Care

Author:

Bouchard Laura C.¹,Aaronson Neil²,Gondek Kathleen³,Cella David¹

Affiliation:

1. Department of Medical Social Sciences, Northwestern University Feinberg School of Medicine, Chicago, IL, USA

2. Division of Psychosocial Research & Epidemiology, The Netherlands Cancer Institute, Amsterdam, The Netherlands

3. Outcomes Research and Epidemiology, Shire Pharmaceuticals, Cambridge, MA, USA

Publisher

Informa UK Limited

Link

https://www.tandfonline.com/doi/pdf/10.1080/23809000.2018.1483193

Reference83 articles.

1. Overall Survival: Still the Gold Standard

2. Progression-Free Survival

3. Overview: Progression-Free Survival as an Endpoint in Clinical Trials with Solid Tumors

4. Progression-Free Survival: Meaningful or Simply Measurable?

Cited by 12 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Improving the clinical meaning of surrogate endpoints: An empirical assessment of clinical progression in phase III oncology trials;International Journal of Cancer;2024-08-13

2. Perceptions and Expectations: A Study on Prognostic Perception and Quality of Life in Patients With Metastatic Renal and Bladder Cancer;JCO Global Oncology;2024-08

3. Are neurologic symptoms associated with worse QoL in non-CNS cancer patients?;Journal of Clinical Neuroscience;2023-05

4. Patient-reported Outcomes in Men with Metastatic Castration-resistant Prostate Cancer Harboring DNA Damage Response Alterations Treated with Talazoparib: Results from TALAPRO-1;European Urology;2023-04

5. An Unsupervised Machine Learning Approach to Evaluating the Association of Symptom Clusters With Adverse Outcomes Among Older Adults With Advanced Cancer;JAMA Network Open;2023-03-22

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3